Female hair loss is more common than most women realise. Over 40% of women experience noticeable thinning by 50. The causes — and the solutions — are different to men.
Female hair loss has many possible causes. Getting the diagnosis right before starting any treatment is essential — the wrong treatment for the wrong type can make things worse.
The most common type. Also known as female androgenetic alopecia. Causes diffuse thinning across the crown and mid-scalp, with the frontal hairline often preserved. Classified on the Ludwig scale (I–III).
Sudden, diffuse shedding triggered by shock to the system — post-partum hair loss, rapid weight loss, crash diets, surgery, illness, or major stress. Usually temporary and self-resolving within 6–12 months.
Autoimmune condition causing patchy loss. Can affect the scalp, eyebrows, eyelashes and body hair. Often unpredictable — patches may regrow spontaneously or progress. Separate page covers this in detail.
Hair loss caused by chronic tension — tight braids, ponytails, extensions and weaves. Begins at the frontal hairline and temples. Reversible in early stages; follicles may permanently scar if tension is prolonged.
Conditions including hypothyroidism, PCOS, and peri-menopause can trigger or accelerate hair loss. Addressing the underlying hormonal imbalance is the first line of treatment before any surgical intervention.
A group of conditions (lichen planopilaris, frontal fibrosing alopecia) that destroy the follicle, leaving permanent scarring. Early diagnosis and treatment is critical. FUE may be possible once the condition is stable.
Yes — FUE hair transplantation is a well-established option for women, but candidacy assessment is more complex than in men. The most important prerequisite is a stable, adequate donor area.
Women with female pattern hair loss (FPHL) where loss is confined to the top of the scalp — with the back and sides remaining dense — are often excellent candidates. The transplanted DHT-resistant follicles will behave permanently.
Women with diffuse unpatterned alopecia (DUPA), where loss affects the entire scalp including the donor zone, are generally not suitable because there is no reliable donor supply.
Traction alopecia affecting the frontal hairline is one of the most gratifying cases to treat surgically — the rest of the scalp is usually unaffected, providing excellent donor density.
Get assessed by DrQ →There are over 50 potential causes of female hair loss, including genetics, hormones, nutritional deficiencies, medication side-effects, stress and autoimmune conditions. An accurate diagnosis before any treatment is essential. DrQ will review your history alongside your photos to advise on likely cause and next steps.
Post-partum hair loss (telogen effluvium) is almost always temporary. Most women see full regrowth within 6–12 months of delivery as hormones stabilise. If shedding continues beyond 12 months, further investigation is warranted.
Finasteride is not licensed for use in women in the UK and is contraindicated in women of childbearing age due to risk of foetal harm. Some women are prescribed it off-label post-menopause under specialist supervision. Minoxidil is the first-line medical treatment for FPHL in women.
It depends on whether the donor area (back and sides of the scalp) is unaffected. If loss is confined to the crown with a dense donor zone, FUE transplantation can be very effective. If thinning is diffuse across the entire scalp, there may be insufficient donor supply for surgery.
Female pattern hair loss (FPHL / androgenetic alopecia) is the most common cause. Hormonal changes around peri-menopause and menopause are a key trigger, as declining oestrogen levels allow androgens to act more prominently on susceptible follicles.
DrQ personally reviews every photo submission. Free, no obligation, and you will receive a response within 1–2 working days.
Start Free Assessment →